Abstract: The present invention relates to an analyzing method of measuring the changes of glycosylation in various glycoproteins which participate in tumorigenesis and metastasis.

Abstract: The invention relates on one hand to a celluloid-free table-tennis ball, preferably having a diameter of 38.5 to 48 mm, a weight between 2.0 and 4.5 grams, and a shell thickness (approximately) between 0.20 mm and 1.30 mm, where the shell is composed of plastic, whose principal component is an organic non-crosslinked polymer, which in its main chain has not only carbon atoms but also heteroatoms; and on the other hand also to a process of manufacturing a table-tennis ball of this kind, where mostly in a first step two or more shell parts are manufactured, these shell parts are joined in a subsequent step.

Abstract: A method comprising transforming Schizosaccharomyces pombe with a deletion cassette, constructed by four-round serial PCR, block PCR or total gene synthesis, containing a homologous recombination site is provided for preparing gene-targeted heterozygous deletion Schizosaccharomyces pombe. Also provided are gene-targeted hetero2ygous deletion Schizosaccharomyces pombe mutants prepared by the method, and a library of gene-targeted heterozygous deletion Schizosaccharomyces pombe mutants. Further, the library is useful in constructing a method and a kit for screening a drug's modes of action.

Abstract: The present invention relates to an analyzing method of measuring the changes of glycosylation in various glycoproteins which participate in tumorigenesis and metastasis.

Abstract: The present invention relates to new heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, a process for the preparation thereof, and a pharmaceutical composition comprising the same for treatment of cancer. The compounds according to the present invention induce DNA damage due to reactive oxygen species to activate c-abl and p53, induce RhoB to generate apoptosis, and induce cell death by down-regulating Bcl2 involved in cell survival, which is generated by dysregulated signals via the mitochondria pathway, thereby inhibiting tumor cell growth and inducing apoptosis. Accordingly, the composition according to the present invention can be used to treat cancer.

Abstract: The present application describes a method of diagnosing gastric cancer or a stage in the progression of the cancer in a subject comprising assaying for loss of expression of a marker gene such as POPDC3, CCDC67, LRRC3B, PRKD1, CYP1B1, LIMS2, DCBLD2, LOC149351, ADCY8, BACH2, ALOX5, TCF4, CXXC4, CAMK2N2, EMX1, KCNK9, NCAM2, AMPD3, NOG, SP6, LOC100128675, or CHSY3, or a combination thereof.

Abstract: The invention relates on one hand to a celluloid-free table-tennis ball, preferably having a diameter of 38.5 to 48 mm, a weight between 2.0 and 4.5 grams, and a shell thickness (approximately) between 0.20 mm and 1.30 mm, where the shell is composed of plastic, whose principal component is an organic non-crosslinked polymer, which in its main chain has not only carbon atoms but also heteroatoms; and on the other hand also to a process of manufacturing a table-tennis ball of this kind, where mostly in a first step two or more shell parts are manufactured, these shell parts are joined in a subsequent step.

Abstract: A microemulsion composition comprising biphenyldimethyldicarboxylate (DDB), a co-surfactant, a surfactant and an oil provides an improved stability and a high in vivo bioavailability of biphenyldimethyldicarboxylate when orally administered.